Atsuya Yamashita

This paper identifies vorapaxar and aripiprazole as inhibitors of HBV replication through distinct host signaling pathways, showing their potential as host-targeting antivirals.

This paper develops a HiBiT-expressing recombinant rat hepacivirus that can infect both in vitro and in vivo, enabling quantitative antiviral screening and pathogenicity studies.

This study identifies claudin-3 as an entry factor for rat hepacivirus, showing host-specificity determined by two amino acids in extracellular loop 1.

This study identifies that HCV infection promotes PA28γ acetylation and heptamerization, enhancing proteasomal degradation of RNF2 and leading to HOX gene expression.

This paper identifies N4BP1 as a host factor that suppresses HBV replication by degrading HBV RNAs, with its KH-like and RNase domains required for this effect.